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Abstract
Objective:  The  aim  of  this  study  was  to  evaluate  the  QuickVue
®
RSV  Test  Kit  (QUIDEL  Corp,  CA,
USA) as  a  screening  tool  for  respiratory  syncytial  virus  in  children  with  acute  respiratory  disease
in comparison  with  the  indirect  immunoﬂuorescence  assay  as  gold  standard.  In  Brazil,  rapid
antigen detection  tests  for  respiratory  syncytial  virus  are  not  routinely  utilized  as  a  diagnostic
tool, except  for  the  diagnosis  of  dengue  and  inﬂuenza.
Methods:  The  authors  retrospectively  analyzed  486  nasopharyngeal  aspirate  samples  from  chil-
dren under  age  5  with  acute  respiratory  infection,  between  December  2013  and  August  2014,
the samples  were  analyzed  by  indirect  immunoﬂuorescence  assay  and  QuickVue
®
RSV  Test  kit.
Samples with  discordant  results  were  analyzed  by  real  time  PCR  and  nucleotide  sequencing.
Results:  From  313  positive  samples  by  immunoﬂuorescence  assays,  282  (90%)  were  also  positive
by the  rapid  antigen  detection  test,  two  were  positive  only  by  rapid  antigen  detection  test,  33
were positive  only  by  immunoﬂuorescence  assays,  and  171  were  positive  by  both  methods.  The
35 samples  with  discordant  results  were  analyzed  by  real  time  PCR;  the  two  samples  positive
only by  rapid  antigen  detection  test  and  the  ﬁve  positive  only  by  immunoﬂuorescence  assays
were also  positive  by  real  time  PCR.  There  was  no  relation  between  the  negativity  by  QuickVue
®
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RSV  Test  and  viral  load  or  speciﬁc  strain.  The  QuickVue
®
RSV  Test  showed  sensitivity  of  90%,
speciﬁcity  of  98.8%,  predictive  positive  value  of  99.3%,  and  negative  predictive  value  of  94.6%,
with accuracy  of  93.2%  and  agreement    index  of  0.85  in  comparison  to  immunoﬂuorescence
assay.
Conclusions:  This  study  demonstrated  that  the  QuickVue
®
RSV  Test  Kit  can  be  effective  in  early
detection  of  Respiratory  syncytial  virus  in  nasopharyngeal  aspirate  and  is  reliable  for  use  as  a
diagnostic tool  in  pediatrics.
© 2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
PALAVRAS-CHAVE
Viroses  Respiratórias;
Virus  Sincicial
Respiratório  --  VSR;
Teste  Rápido  de
Detecc¸ão  de  Antígeno
--  TRDA
Teste  rápido  de  detecc¸ão de  antígenos  para  o  diagnóstico  do  Vírus  Sincicial
Respiratório  como  ferramenta  de  diagnóstico
Resumo
Objetivo:  Avaliar  o  teste  QuickVue
®
RSV  Test  Kit  (QUIDEL  Corp,  CA,  EUA)  para  o  diagnóstico
rápido do  vírus  sincicial  respiratório  em  crianc¸as  com  doenc¸a  respiratória  aguda,  comparando-
o com  a  imunoﬂuorescência  indireta  como  padrão  ouro.  Visto  que,  no  Brasil,  testes  rápidos  para
detecc¸ão de  antígenos  para  vírus  sincicial  respiratório  não  são  rotineiramente  utilizados  como
ferramenta  de  diagnóstico,  exceto  para  Dengue  e  Inﬂuenza.
Métodos:  Um  total  de  486  amostras  de  aspirado  de  nasofaringe  de  crianc¸as  menores  de  5  anos
com doenc¸a  respiratória  aguda,  coletadas  entre  dezembro  de  2013  e  agosto  de  2014,  foram  anal-
isadas por  imunoﬂuorescência  e  pelo  teste  QuickVue
®
.  Amostras  com  resultados  discordantes
entre os  métodos  foram  submetidas  a  PCR  em  tempo  real  e  sequenciamento.
Resultados:  Das  313  amostras  positivas  por  IFI,  282  foram  positivas  no  teste  rápido  (90%),
2 amostras  foram  positivas  apenas  no  teste  rápido  (0.6%),  33  apenas  na  imunoﬂuorescência
(10.5%) e  171  foram  negativas  em  ambos  os  métodos.  As  35  amostras  com  resultados  discor-
dantes foram  testadas  por  PCR  em  tempo  real,  sendo  que  duas  que  foram  positivas  apenas  no
teste rápido  e  5  apenas  na  imunoﬂuorescência  conﬁrmaram-se  positivas.  Não  houve  relac¸ão
entre a  ausência  de  positividade  no  teste  QuickVue
®
com  a  carga  ou  com  a  cepa  viral.  O  teste
QuickVue
®
mostrou  sensibilidade  de  90.1%,  especiﬁcidade  98.9%,  valor  preditivo  positivo  99.3%,
valor preditivo  negativo  de  94.6%,  acurácia  de  93.2%  e  índice    de  concordância  de  0.85  em
comparac¸ão à  imunoﬂuorescência.
Conclusões:  Nosso  estudo  demonstrou  que  o  teste  QuickVue
®
RSV  pode  ser  efetivo  na  detecc¸ão
precoce do  vírus  sincicial  respiratório  em  amostras  de  aspirado  de  nasofaringe  e  é  conﬁável
como uma  ferramenta  de  diagnósticos  em  pediatria.
© 2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´ um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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espiratory  syncytial  virus  (RSV)  is  known  as  a  major
nfectious  agent  of  respiratory  tract  infections  in  children
orldwide.1 Most  children  are  infected  in  the  ﬁrst  year  of
ife,  but  virtually  all  will  be  exposed  by  age  2.2 Reinfec-
ions  are  common  throughout  life,  depending  on  the  level
f  neutralizing  antibodies  in  the  serum,  but  complications
n  lower  respiratory  tract  infections  are  more  common  in
rimary  infection.3 RSV  is  primarily  replicated  in  superﬁcial
ortions  of  the  respiratory  tract,  until  it  spreads  through
he  epithelium,  forming  a  syncytia-like  cytopathic  effect.
SV  has  two  known  sub-groups:  A  and  B,  and  it  can  cause  a
ange  of  clinical  conditions,  from  the  common  cold  to  bron-
hiolitis  and  pneumonia,  which  are  caused  by  necrosis  of
he  bronchi  and  bronchioles.  The  World  Health  Organiza-
ion  (WHO)  estimates  that  RSV  infects  64  million  people  and
auses  160,000  deaths  per  year  worldwide.4 The  seasonality
T
u
if  the  virus  varies,  and  it  is  often  detected  throughout  the
ear.  However,  it  is  known  that  the  highest  incidence  occurs
n  the  winter  season.
The  viral  diagnosis  of  RSV  can  be  accomplished  by  a  num-
er  of  methods,  including:  cell  culture,  immunoﬂuorescence
ssays  (IFA),  immune  chromatographic  assays  (rapid  anti-
en  detection  tests:  RADTs),  and  polymerase  chain  reaction
PCR),  including  conventional  and  real-time  PCR  assays.  In
he  last  decade,  the  molecular  methods  have  been  used
s  the  gold  standard,  because  of  their  speciﬁcity  and  abil-
ty  to  simultaneously  detect  different  viruses.5 In  Brazil,
lthough  there  are  at  least  four  RADTs  available  for  RSV
etection  (BD-DirectigenTMEZ-RSV  [Becton,  Dickinson  and
ompany
®
,  NJ,  USA];  SASTM  RSValert  [Medivax
®
,  RJ,  Brazil];
lereTMBinaxNow
®
RSV  [AlereTM,  USA];  and  QuickVue
®
RSVest  Kit  [QUIDEL  Corp.,  CA,  USA]),  they  are  not  routinely
tilized  in  the  country  as  a  reliable  diagnostic  for  viral
nfections,  such  as  RSV,  with  the  exception  of  human
 IN PRESS+Model
3
NPA samples
486
RSV positive
313
RSV negative
100
RSV-/Other
virus+
73
Figure  1  Work  ﬂowchart.  Nasopharyngeal  aspirate  samples
were divided  into  three  distinct  groups  screened  by  immuno-
ﬂuorescence  assay  and  compared  with  rapid  antigen  detection
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RADT  for  RSV  as  a  screening  tool  in  pediatrics  
immunodeﬁciency  virus  (HIV)  and  dengue  tests,6,7 which  are
widely  used.
The  rapid  test  to  be  evaluated  in  this  study  (QuickVue
®
RSV  Test  Kit,  Quidel
®
)provides  a  result  in  15  min,  compared
to  approximately  90  min  for  a  conventional  IFA  test  and
2--3  h  for  enzyme  (ELISA).8 Quickly  identifying  the  etiologic
agent  of  respiratory  diseases,  such  as  bronchitis  and  bron-
chiolitis,  is  an  important  step  toward  reducing  the  use  of
antimicrobials,  especially  in  hospitalized  children,9 and  can
also  indicate  the  most  appropriate  method  of  isolation  and
treatment.
The  QuickVue
®
RSV  test  is  a  dipstick  immunoassay,  which
allows  for  the  rapid,  qualitative  detection  of  RSV  anti-
gen  (viral  fusion  protein)  directly  from  nasopharyngeal
swab,  nasopharyngeal  aspirate,  or  nasal/nasopharyngeal
wash  specimens  from  symptomatic  pediatric  patients.  The
test  is  intended  for  use  as  an  aid  in  the  diagnosis  of  acute
respiratory  syncytial  viral  infections.
The  aim  of  this  study  is  to  evaluate  sensitivity,  speciﬁcity,
and  importance  of  the  QuickVue
®
RSV  Test  Kit  as  a  RADT  for
screening  and  improvement  of  RSV  diagnosis  in  the  nasopha-
ryngeal  aspirate  of  children  with  acute  respiratory  disease
compared  with  indirect  IFA,  for  use  in  hospitals  and  pediatric
clinical  practices.
Materials and methods
The  authors  retrospectively  analyzed  nasopharyngeal  aspi-
rate  (NPA)  samples  from  486  children  --  274  boys  (56.4%)  and
212  girls  (43.6%)  --  under  ﬁve  years  old  with  symptoms  of
acute  respiratory  infection  (ARI),  including  upper  and  lower
respiratory  tract  disease,  in  the  period  between  December
2013  and  August  2014,  who  had  ARI  and  were  cared  for
in  the  emergency  room,  as  outpatients,  or  hospitalized  in
the  Pediatrics  Department,  University  Hospital,  University
of  São  Paulo  (HU-USP).
Clinical  samples  were  collected  during  the  RSV  outbreak
of  2014  using  mucus  trap.  Immediately  following  collection,
the  samples  were  sent  to  the  University  of  São  Paulo  Hospital
Laboratory  and  screened  by  indirect  IFA  using  a  commercial
Kit  Light  DiagnosticsTM Respiratory  Panel  Viral  Screening  and
Identiﬁcation  (IFA  Chemicon
®
,  Merk  Millipore  Corp.,  USA)
following  the  manufacturer’s  instructions.  These  samples
were  then  sent  to  the  Clinical  and  Molecular  Virology  Labora-
tory  at  the  Institute  of  Biomedical  Sciences  of  the  University
of  São  Paulo,  where  they  were  frozen  by  cryogenics,  and
stored  at  −80 ◦C  until  the  time  of  testing.  All  the  samples
were  registered  at  the  Virology  Laboratory  Biorepository,
and  all  ethics  guidelines  for  human  experimentation  were
strictly  observed  and  approved  by  the  Ethics  Committee  on
Research  with  Human  Beings  at  the  University  of  São  Paulo
(USP).
Based  on  the  IFA  results,  486  NPA  samples  distributed
during  all  the  months  of  the  season  were  selected,  corre-
sponding  to  50.4%  of  all  the  samples  analyzed.  They  were
classiﬁed  into  three  distinct  groups  as  shown  in  Fig.  1.  To
reduce  or  eliminate  any  bias,  the  QuickVue
®
RSV  assay  wasperformed  and  analyzed  in  a  blind  trial,  and  results  were
compared  with  the  original  results  from  the  IFA  Kit.
In  order  to  conﬁrm  the  results,  samples  with  discrepant
results  were  subsequently  tested  by  real-time  quantitative
p
Q
test for  respiratory  syncytial  virus.  RSV,  respiratory  syncytial
irus;  NPA,  nasopharyngeal  aspirate;  +,  positive;  −, negative.
everse  transcription  PCR  (F  protein  region)  and  by  tradi-
ional  PCR  (G  and  F  protein  regions).
Samples  were  extracted  on  the  NUCLISENS
®
easyMag
®
latform  (bioMérieux
®
, MA,  USA)  and  real-time  PCR  per-
ormed  on  ABI  7300  instrumentation  utilizing  the  AgPath-ID
ne-Step  RT-PCR  master  mix  kit  (Ambion
®
, TX,  USA)  follow-
ng  the  manufacturer’s  instructions.
For  traditional  PCR,  the  authors  used  a reaction  mix-
ure  containing  10  L  of  cDNA,  5  L of  PCR  buffer  reaction
0×  concentration  (50  mM  Tris--HCl  [pH  9.0],  1.0  L  of  MgCl2
50  mM  KCl,  20  mM  [NH4)2SO4]),  2.5  mM  of  each  dNTPs,
0  pmol  of  each  primer  for  RSV  (Table  1),  0.6  U  of  Taq  DNA
olymerase  (platinum  taq  DNA  polymerase,  Invitrogen,  CA,
SA)  and  water,  resulting  in  a  ﬁnal  volume  of  50  L.  Ampli-
cation  of  protein  G  and  F  was  performed  in  a  GeneAmp
CR  System  9700  (Applied  Biosystems,  Inc.,  CA,  EUA)  ther-
ocycler  according  to  the  following  program:  95 ◦C  for  ﬁve
in,  followed  by  40  cycles  of  95 ◦C  for  30  s,  54 ◦C  for  30  s,
2 ◦C  for  90  s,  and  one  last  seven  min  cycle  at  72 ◦C.  Approxi-
ately  1894  bp  products  of  G  gene10--12 and  1685  bp  products
f  F  gene13 were  puriﬁed  with  a  commercial  kit  (Exosap,
E
®
Tech,  CA,  USA),  according  to  the  manufacturer’s  instruc-
ions.  Sequence  reactions  of  the  G  gene10--13 and  the  F
ene13,14 were  subjected  to  electrophoretic  separation  for
rimary  data  collection  in  a  3130  DNA  sequencer  (Applied
iosystems,  Inc.,  CA,  EUA),  using  a  ﬂuorescent  dye  termina-
or  kit  (Applied  Biosystems,  Inc.).  Sequences  obtained  were
dited  with  the  Sequence  Navigator  program  version  1.0
Applied  Biosystems,  Inc.,  CA,  EUA)  and  aligned  using  the
rogram  Megalign  (Lacergene,  DNA  STAR,  Inc.,  WI,  USA).  A
aximum  likelihood  phylogeny  of  G  protein  was  estimated
sing  MEGA  615,16 with  gamma  distribution  (TN93  +  G)  for  the
SV  A data  set  and  model  with  gamma  distribution  (HKY  +  G)
or  HRSVB.17 The  phylogenetic  tree  that  resulted  was  mid-
oint  rooted.
The  criteria  used  for  the  performance  assessment  of
uickVue
®
RSV  assay  were  sensitivity,  speciﬁcity,  posi-
ive  and  negative  predictive  values,  and  positive/negative
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Table  1  Primers  used  for  traditional  polymerase  chain  reaction  (PCR)  and  sequencing  of  G  and  F  respiratory  syncytial  virus
(RSV) proteins.
Primer  name  Target  protein  Genome  position  Reaction  Sequence  5′-3′ Reference
FV-a AB  G  186--163/Gene  F  PCR  GTTATGACACTGGTATACCAACC  Zheng  et  al.10
SH+  AB  G  3924--3948/Gene  M  PCR  CAGCTACACGTTTTTCAATCAAACC  Lima  et  al.11
OG1+  21a G  1--21/Gene  G  SANGER  GGGGCAAATGCAACCATGTCC  Trento  et  al.12
GAB+a,b G/F  504--524/Gene  G  PCR  YCAYTTTGAAGTGTTCAACTT  Peret  et  al.13
BO2--  ABb F  1216--1199/Gene  F  PCR  ATCTGTTTTTGAAGTCAT  Arbiza  J.c
F1AB+b F  3--22/Gene  F SANGER  GGTTGGTATACCAGTGTCATAAC  Modif.  Peret  et  al.14
FP2+ ABb F  573--595/Gene  F SANGER  TTAACCAGCAAAGTGTTAGACC In  House
G, glycoprotein; F, fusion protein; M, matrix protein.
a Primer used in G gene sequencing.
 Sciences, University of the Republic, Montevideo, Uruguay.
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Table  2  Results  of  respiratory  syncytial  virus  (RSV)  pos-
itive and  negative  by  indirect  immunoﬂuorescence  assay
(IFA) and  rapid  antigen  detection  test  (RADT)  and  the
totality  of  divergent  samples  tested  in  this  study.  (A)
Rapid-antigen  detection  test  results  compared  with  IFA.  (B)
Discrepant  results.  (C)  Comparison  of  rapid  test  evalua-
tion parameters  including  sensitivity,  speciﬁcity,  predictive
positive  value  (PPV),  negative  predictive  value  (NPV),
and positive/negative  diagnostic  likelihood  ratio  (DLR),  for
QuickVue
®
RSV  test  compared  to  IFA,  used  as  the  gold
standard.
RADT  (test)  Number  of  samples
IFA  (gold  standard)  Total
Positive  Negative
Positive  282  2  284
Negative  31  171  202
Total 313  173  486
Results Number  of  samples
IFA+,  RADT−,  qPCR+ 26
IFA−, RADT+,  qPCR+  2
IFA+,  RADT−,  qPCR−  5
IFA−, RADT+,  qPCR−  0
Parameter  95%  CI
Sensitivity  (%)  90.1  (86.8--93.4%)
Speciﬁcity  (%)  98.8  (97.2--100)
PPV  (%)  99.3  (98.3--100%)
NPV  (%)  94.6  (79.6--89.6)
Positive  DLR  77.9  (19.6--309.26)
s
mb Primer used in F gene sequencing.
c Courtesy of Dr. Juan Arbiza, Laboratory of Virology, Faculty of
iagnostic  likelihood  ratios  (DLRs).18,19 IFA  was  considered
s  the  gold  standard  for  these  analyses.  Samples  positive
y  IFA  were  considered  to  be  true  positives,  and  samples
hat  were  negative  by  IFA  were  considered  to  be  true  neg-
tives.  For  accurate  evaluation  of  the  agreement  between
he  methods,  the  kappa  index  ()  was  also  assessed.
esults
ADT
f  the  313  NPA  samples  positive  for  RSV  by  IFA,  282  (90%)
ere  also  positive  by  the  rapid  test  (QuickVue
®
RSV  test),
hus  the  RADT  test  revealed  31  false  negative  results.  All
he  100  NPA  samples  negative  for  RSV  by  IFA  were  also  neg-
tive  by  the  rapid  test  (100%).  Of  73  NPA  samples  that  were
egative  for  RSV  but  positive  for  other  respiratory  virus  (AdV
r  PIV  1,  2,  3  or  Flu  A  and  Flu  B)  by  IFA,  71  (97.26%)  were
onﬁrmed  by  the  rapid  test,  and  two  (2.74%)  had  divergent
esults,  revealing  two  false  positive  results  (Table  2A).
iscrepant  results  tested  by  real-time  PCR
he  33  samples  with  discordant  results  between  the  two
ethods  were  analyzed  by  real-time  PCR  (Table  2B).
Twenty-six  NPA  samples  that  were  previously  considered
ositive  by  IFA  and  negative  by  rapid  test  were  conﬁrmed
s  positive  for  RSV  by  real-time  PCR.  The  two  NPA  samples
onsidered  negative  by  IFA  and  positive  by  the  rapid  test
ere  actually  positive  by  qPCR.  And  the  ﬁve  NPA  samples
onsidered  positive  by  IFA  and  negative  by  the  rapid  test
ere  negative  by  qPCR.  The  real-time  PCR  threshold  cycle
Ct)  values  of  the  26  positive  samples  ranged  from  14  to  37
ycles.
In  order  to  understand  if  the  differences  between  the
ests  were  related  to  a  speciﬁc  genotype  (RSV  A  or  RSV  B)
r  a  genetic  variability  in  the  F  protein  of  the  virus,  the
 protein  of  all  26  samples  with  divergent  results  were
equenced  and  there  were  22  consensuses  for  further  anal-
sis.  After  sequencing,  the  results  showed  that  all  the  12
SV  A  sequences  were  from  the  novel  genotype  ON1  and  all
en  RSV  B  sequences  were  from  the  new  BA11  (three)  and
A9  (seven)  genotypes  (Fig.  2).
n
g
m
sNegative  DLR  0.1  (0.071--0.14)
In  order  to  verify  if  the  negativity  in  RADT  of  positive
amples  with  high  load  viral  were  associated  to  a  speciﬁc
utation  in  the  fusion  (F)  protein  of  RSV,  the  ﬁrst  1200
ucleotides  of  the  gene  from  the  26  samples  with  diver-
ent  results  were  sequenced  and  did  not  reveal  a  speciﬁc
utation  that  could  be  associated  with  the  negativity  of  the
amples  in  the  RADTs  (data  not  shown).
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Figure  2  Human  respiratory  syncytial  virus  (HRSV)  maximum  likelihood  phylogenetic  tree  based  on  nucleotide  sequences  of  the
G protein  of  the  discrepant  samples  from  this  work,  indicated  as  BRSP,  and  worldwide  distributed  strains  obtained  from  GenBank.
GenBank accession  numbers  are  given  in  each  taxon  followed  by  the  correspondent  name  of  the  strain.  Initial  tree(s)  for  the
heuristic search  were  obtained  by  applying  the  neighbor-joining  method  to  a  matrix  of  pairwise  distances  estimated  using  the
maximum composite  likelihood  (MCL)  approach.  The  trees  were  drawn  to  scale,  with  branch  lengths  measured  in  the  number  of
substitutions  per  site.  Numbers  at  the  internal  nodes  represent  the  bootstrap  probabilities  (5000  replicates).  Only  bootstrap  values
>50 are  shown.  (A)  HRSVA.  The  evolutionary  history  was  inferred  by  using  the  maximum  likelihood  method  based  on  the  Tamura--Nei
15,16 11)  i
a--Kis
.15
d
n
c
c
t
t
s
a
t
A
cmodel. The  tree  with  the  highest  log  likelihood  (−1303.67
using the  maximum  likelihood  method  based  on  the  Hasegaw
(−1207.4096)  is  shown.  The  analyses  were  conducted  in  MEGA  6
Statistical  analysis
The  performance  of  the  QuickVue
®
RSV  test  compared  to  IFA
are  represented  in  Table  2.  The  accuracy  was  93.2%  (95%  CI:
91.0--95.4%)  and  the  agreement    index  between  the  meth-
ods  was  0.85  (95%  CI:  0.945--0.769),  which  was  ranked  as
almost  perfect,20 with  p  <  0.001.
The  analysis  of  the  discordant  and  concordant  results
between  the  methodologies  showed  no  signiﬁcance
(p  =  0.62,  p  =  0.065  in  the  chi-squared  test,  respectively).
DiscussionThe  aim  of  this  study  was  to  prove  that  the  rapid  test  is
efﬁcient  for  RSV  detection  and  to  encourage  its  use  in  Brazil,
as  it  is  currently  done  for  dengue,  inﬂuenza,  and  HIV.
n
a
a
Rs  shown.  (B)  HRSVB.  The  evolutionary  history  was  inferred  by
hino--Yano  model.17 The  tree  with  the  highest  log  likelihood
The  hallmark  of  RSV  infection  is  bronchiolitis,21 and  its
iagnosis  is  generally  made  by  clinical  condition.22 Although
ot  recommended,  the  prescription  of  antibiotics  for  bron-
hiolitis  is  an  extremely  common  practice  in  hospitalized
hildren,9,23 and  their  use  is  associated  with  an  increase  in
he  cost  and  time  of  hospitalization24 and  an  increase  of
he  risk  of  development  of  resistant  bacterial  strains.25 In
evere  cases,  especially  in  intensive  care  units,  antibiotics
re  commonly  used  to  avoid  a  potential  bacterial  infec-
ion,  although  the  risk  in  healthy  infants  is  uncommon.26
 systematic  review  that  analyzed  four  studies  involving
hildren  attending  the  emergency  room  suggested  that  diag-
24ostic  tests  could  reduce  the  prescription  of  antibiotics,
s  was  veriﬁed  in  a  study  with  infants  under  1  year  of
ge  hospitalized  with  bronchiolitis  and  tested  positive  for
SV  by  IFA  that  described  a  signiﬁcant  decrease  in  the  use
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f  antibiotics.27 If  the  diagnostic  test  is  positive,  it  can
ontribute  to  prevent  the  use  of  antibiotics.  In  doubtful
ases  that  are  not  severe,  the  patient  should  stay  under
bservation.
Since  the  result  using  a  rapid  test  is  available  in  15  min
nd  it  is  performed  by  the  doctor  without  the  need  of  lab-
ratory  equipment,  the  rapid  test  would  be  used  for  this
creening,  as  a  point  of  care  assay.
In  this  context,  the  authors’  work  showed  that  the
uickVue
®
RSV  Test  is  reliable  for  this  task,  as  can  be  seen
y  the  results  of  the  performance  in  comparison  to  indi-
ect  immunoﬂuorescence  assay  (IFA)  used  as  gold  standard
n  this  study.  All  the  parameters  analyzed  were  high  (greater
han  90%  --  sensitivity  of  90%,  speciﬁcity  of  98.8%,  PPV
f  99.3%,  and  NPV  of  94.6%)  and  were  similar  to  those
f  other  studies  that  compared  RADT  with  IFA  as  the  gold
tandard,  which  ranged  from  73%  to  93%  sensitivity  and  84%
o  100%  speciﬁcity.28 In  contrast,  in  2015  Leonardi  et  al.29
valuated  four  RSV  direct  antigen  detection  assays  and
heir  results  presented  only  57.5%  sensitivity  for  QuickVue
®
,
lthough  this  difference  may  be  due  to  the  comparison
ith  RT-qPCR,  which  has  a  higher  sensitivity  and  speciﬁcity
han  IFA.
In  addition,  the  overall  agreement  (kappa  index)  and
ccuracy  between  the  two  tests  were  considered  good,
nd  the  negative  and  positive  percent  agreement  (173/202
nd  284/313  respectively)  showed  no  signiﬁcant  differ-
nce  (p  >  0.05).  Only  33  samples  showed  divergent  results
etween  the  tests;  they  were  analyzed  by  RT-qPCR  in  order
o  conﬁrm  the  results  and  to  correlate  the  sensitivity  of  the
est  with  a  low  viral  load,  as  it  was  observed  by  Tuttle  et  al.30
wenty-six  samples  continue  to  be  unsolved  after  this  anal-
sis,  and  the  authors  also  could  not  explain  the  differences
y  the  load  viral,  since  the  qPCR  threshold  cycle  ranged
rom  14  to  37.  Maybe  these  false  negative  results  could
e  related  to  the  storage  of  frozen  specimens  before  their
nalysis.
Next,  in  order  to  understand  if  these  differences  were
elated  to  a  speciﬁc  genotype  (RSV  A  or  RSV  B)  or  a  genetic
ariability  in  the  F  protein  of  the  virus,  the  G  and  F  genes
ere  sequenced.  The  G  sequences  analysis  showed  that
hey  belonged  to  genotypes  ON1  and  BA-like  insertion  (vari-
nts  BA11  and  BA9).  However,  other  samples  in  this  study
hat  showed  positive  results  by  QuickVue
®
RSV  Test  were
equenced  (data  not  shown)  and  belonged  to  the  same
enotypes,  proving  that  the  negativity  is  not  related  to
hese  genotypes.  This  study  did  not  identify  any  mutation
n  the  F  gene  that  could  be  responsible  for  the  results.  The
nal  approach  was  to  look  for  inhibition  caused  by  chem-
cal  elements  in  the  samples  as  an  inhibition,  nonetheless
alse  negative  specimens  were  diluted  (1:5  and  1:10),  but
emained  negative.
In  conclusion,  the  QuickVue
®
RSV  Test  Kit  displayed  high
redictive  values  and  likelihood  ratios,  and  it  proved  to  be
ffective  in  early  detection  of  RSV.  Nevertheless,  depending
n  the  patient’s  improvement,  it  is  recommended  that  the
est  must  be  repeated  in  case  of  negativity.  Therefore,  this
tudy  demonstrated  that  the  QuickVue
®
RSV  Test  Kit  can  be
ffective  in  early  detection  of  RSV  in  frozen  nasopharyngeal
spirate  specimens  and  is  suitable  for  use  as  a  diagnostic
ool  in  pediatrics. PRESS
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